Bicara Therapeutics (BCAX) Stock Chart & Stock Price History $9.20 -0.26 (-2.75%) Closing price 04:00 PM EasternExtended Trading$9.27 +0.07 (+0.76%) As of 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Bicara Therapeutics Stock Price Performance The Bicara Therapeutics (BCAX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 47.19%. In the past month, the stock has decreased 7.07%, reflecting recent market activity. As of the latest close, Bicara Therapeutics traded at $9.46 with a market cap of $515.95 million and volume of 1.07 million shares. Receive BCAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.63%1 Month Performance-7.07%3 Month Performance-30.62%Year-To-Date Performance-47.19% BCAX Stock Chart for Wednesday, July, 2, 2025 BCAX Chart by TradingView Bicara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$9.46$9.20-2.75%$10.02$9.20493,153 shs$501.77 million07/01/2025$9.29$9.46+1.83%$9.68$8.821.07 million shs$515.95 million06/30/2025$8.71$9.29+6.66%$9.42$8.581.07 million shs$506.68 million06/27/2025$8.81$8.71-1.14%$9.02$8.662.70 million shs$475.04 million06/26/2025$8.94$8.81-1.45%$9.28$8.481.05 million shs$480.50 million06/25/2025$9.51$8.94-5.99%$9.80$8.86872,133 shs$487.59 million06/24/2025$9.18$9.51+3.59%$9.75$9.09653,458 shs$518.64 million06/23/2025$9.32$9.18-1.50%$9.50$9.05507,654 shs$500.68 million06/20/2025$9.43$9.32-1.17%$9.78$9.08581,796 shs$508.31 million06/19/2025$9.43$9.43$9.83$9.29725,901 shs$514.27 million Get the Latest News and Ratings for BCAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$9.67$9.43-2.48%$9.83$9.29725,901 shs$514.31 million06/17/2025$10.00$9.67-3.30%$10.81$9.62620,739 shs$527.36 million06/16/2025$10.84$10.00-7.75%$11.06$9.94544,088 shs$545.36 million06/13/2025$11.57$10.84-6.31%$11.57$10.73443,114 shs$591.17 million06/12/2025$11.88$11.57-2.61%$12.05$11.38472,922 shs$630.98 million06/11/2025$12.58$11.88-5.56%$12.74$11.76515,851 shs$647.89 million06/10/2025$11.48$12.58+9.58%$12.72$11.59574,767 shs$686.06 million06/09/2025$11.50$11.48-0.17%$11.75$11.15746,497 shs$626.07 million06/06/2025$11.03$11.50+4.26%$11.84$10.371.12 million shs$627.16 million06/05/2025$11.16$11.03-1.16%$11.35$10.501.22 million shs$601.53 million06/04/2025$11.01$11.16+1.36%$12.08$10.802.27 million shs$608.62 million06/03/2025$9.90$11.01+11.21%$11.21$9.713.06 million shs$600.44 million06/02/2025$9.28$9.90+6.68%$10.32$9.302.06 million shs$539.91 million Related Companies DNLI Stock Chart NAMS Stock Chart AGIO Stock Chart SRPT Stock Chart CGON Stock Chart APGE Stock Chart INDV Stock Chart BLTE Stock Chart IDYA Stock Chart HRMY Stock Chart Receive BCAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCAX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCAX Stock Alerts